Related references
Note: Only part of the references are listed.SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans
Aili L. Lazaar et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases
Michelle L. Varney et al.
CANCER LETTERS (2011)
SNAIL Regulates Interleukin-8 Expression, Stem Cell-Like Activity, and Tumorigenicity of Human Colorectal Carcinoma Cells
Wei-Lun Hwang et al.
GASTROENTEROLOGY (2011)
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Yan Ning et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Phosphatidylinositol 3-Kinase γ Inhibition Ameliorates Inflammation and Tumor Growth in a Model of Colitis-Associated Cancer
Ana Gonzalez-Garcia et al.
GASTROENTEROLOGY (2010)
Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury
ZhiYao Bao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2010)
Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival
Dietrich Doll et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2010)
Host CXCR2-Dependent Regulation of Melanoma Growth, Angiogenesis, and Experimental Lung Metastasis
Seema Singh et al.
CANCER RESEARCH (2009)
Small-Molecule Antagonists for CXCR2 and CXCR1 Inhibit Human Melanoma Growth by Decreasing Tumor Cell Proliferation, Survival, and Angiogenesis
Seema Singh et al.
CLINICAL CANCER RESEARCH (2009)
Regulation of deoxycholate induction of CXCL8 by the adenomatous polyposis coli gene in colorectal cancer
Nathaniel S. Rial et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Tumor immunotherapy in melanoma - Strategies for overcoming mechanisms of resistance and escape
Maya Zigler et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2008)
Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
G. Lurje et al.
ANNALS OF ONCOLOGY (2008)
Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab
Anne M. Schultheis et al.
CLINICAL CANCER RESEARCH (2008)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Akt pathway in oncogenesis and as a target for anti-cancer therapy
Jin Q. Cheng
CURRENT CANCER DRUG TARGETS (2008)
Chemotherapy-Induced CXC-Chemokine/CXC-Chemokine Receptor Signaling in Metastatic Prostate Cancer Cells Confers Resistance to Oxaliplatin through Potentiation of Nuclear Factor-kappa B Transcription and Evasion of Apoptosis
Catherine Wilson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth
William M. Merritt et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Chemokines in tumor angiogenesis and metastasis
Seema Singh et al.
CANCER AND METASTASIS REVIEWS (2007)
Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability
Melissa L. Petreaca et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells
P. J. Maxwell et al.
ONCOGENE (2007)
Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells
Chen Yao et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Interleukin-8 is a molecular determinant of androgen independence and progression in prostate cancer
Shinako Araki et al.
CANCER RESEARCH (2007)
Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07
J. Philip Kuebler et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Discovery of 2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123):: A potent, orally bioavailable CXCR2/CXCR1 receptor antagonist
Michael P. Dwyer et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Involvement of IL-8 in COX-2-mediated bone metastases from breast cancer
Balrai Singh et al.
JOURNAL OF SURGICAL RESEARCH (2006)
Cancer CXC chemokine networks and tumour angiogenesis
RM Strieter et al.
EUROPEAN JOURNAL OF CANCER (2006)
Genetic variation in IL-8 associated with increased risk and poor prognosis of breast carcinoma
Kaouther Snoussi et al.
HUMAN IMMUNOLOGY (2006)
Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation
MA Gordon et al.
PHARMACOGENOMICS (2006)
Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan
A Taguchi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
The-251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in chinese population
WP Lee et al.
CLINICAL CANCER RESEARCH (2005)
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
DJ Brat et al.
NEURO-ONCOLOGY (2005)
MEK1-dependent delayed expression of Fos-related antigen-1 counteracts c-Fos and p65 NF-κB-mediated interleukin-8 transcription in response to cytokines or growth factors
E Hoffmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The polymorphism interleukin 8-2251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population
M Ohyauchi et al.
GUT (2005)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: Prevention of reperfusion injury
R Bertini et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
A Sparmann et al.
CANCER CELL (2004)
Alteration of gene expression in normal-appearing colon mucosa of APCmin mice and human cancer patients
LC Chen et al.
CANCER RESEARCH (2004)
The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis
RC Bates et al.
EXPERIMENTAL CELL RESEARCH (2004)
To be, or not to be:: NF-κB is the answer -: role of Rel/NF-κB in the regulation of apoptosis
J Kucharczak et al.
ONCOGENE (2003)
IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis
AH Li et al.
JOURNAL OF IMMUNOLOGY (2003)
Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2
J Heidemann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
NF-κB, chemokine gene transcription and tumour growth
A Richmond
NATURE REVIEWS IMMUNOLOGY (2002)
Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma
SY Huang et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
NF-κB in cancer:: From innocent bystander to major culprit
M Karin et al.
NATURE REVIEWS CANCER (2002)
Interleukin-8 and human cancer biology
KP Xie
CYTOKINE & GROWTH FACTOR REVIEWS (2001)
Interleukin 8 and vascular endothelial growth factor - prognostic factors in human gastric carcinomas?
S Kido et al.
EUROPEAN JOURNAL OF CANCER (2001)
Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families
J Hull et al.
THORAX (2000)
Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer
A Yuan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-κB- and AP-1-dependent mechanism
TS Collins et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
Chemokines: A new classification system and their role in immunity
A Zlotnik et al.
IMMUNITY (2000)
Share Paper
